Investor Relations

English Español Português Deutsch

Khiron Begins Sales of First High-THC Medical Cannabis in Colombia

View Press Release View All

May 7, 2020 • 4:05 PM EDT

Khiron to Present at Canaccord Genuity's Global Cannabis Virtual Conference

May 6, 2020 • 12:01 AM EDT

Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21

May 1, 2020 • 6:05 PM EDT

Khiron Life Sciences Reports 2019 Fiscal Year End Results and Provides Corporate Update

View Presentation

Recent Events

May 12, 2020 • 11:40 am EDT

Canaccord Genuity Virtual Cannabis Conference

View Event

May 4, 2020 • 10:00 am EDT

YE 2019 Financial Statements Call

View Event

View All

FY 2019

Fiscal Year Ended Dec 31, 2019

Earnings Release

PDF HTML

Company Overview

Khiron Life Sciences is a Latin American Cannabis Company with Global Growth with its core operations in Colombia. Khiron combines leading international scientific expertise, agricultural advantages and branded product market entrance experience to address the unmet medical needs in a market of over 620 million people in LatAm.

View Management Team View Board of Directors

Investor Contact Information

Company

Khiron Life Sciences Corp.
100 King Street West
Suite 1600
Toronto, Ontario M5X 1A9
Canada